Skip to main content

Vir Biotechnology, Inc.

VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001706431

No open-market purchases or sales by Vir Biotechnology, Inc. insiders were filed in the last 90 days; 237 institutions reported holding it in 13F filings for Q2 2026, worth $1.49B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Vir Biotechnology, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Vir Biotechnology, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Vir Biotechnology, Inc.
NameTitleLast reported holdingLast filingFilings, past year
More Robert JDirector517,917IndirectAug 12, 20262
Coughlin TimothyDirector16,000Jun 10, 20261
Napolitano JanetDirector21,216Jun 2, 20262
Sabatini BrentSVP, Chief Accounting Officer61,902Jun 2, 20265
Bischofberger Norbert WDirector21,333May 28, 20261
Hatfield Jeffrey S.Director39,806May 28, 20261
Sigal Charles ElliottDirector39,806May 28, 20261
Farid RamyDirector32,000May 28, 20261
Sato Vicki LDirector1,078,391May 4, 20269
De Backer MariannePresident and CEO286,650IndirectApr 30, 20264
O'Byrne JasonEVP & Chief Financial Officer2,500IndirectMar 23, 20264
Eisner MarkEVP and Chief Medical Officer154,024Feb 26, 20262
de Verneuil VaninaEVP, General Counsel, Corp Sec112,982Feb 26, 20264
SB Investment Advisers (UK) Ltd10% Owner13,728,924IndirectDec 3, 202511
Softbank Vision Fund (Aiv M1) L.P.10% Owner13,728,924IndirectDec 3, 202511
SVF Endurance (Cayman) Ltd10% Owner13,728,924IndirectDec 3, 202511
Ramasastry SairaDirector22,619Jun 2, 20250
Scangos George ADirector698,239Feb 25, 20250
Hanly Ann M.EVP & Chief Technology Officer117,901Feb 25, 20250
Nelsen RobertDirector584,148Jun 3, 20240
Lee SungEVP & Chief Financial Officer100,492Mar 28, 20240
Pang PhillipEVP & Chief Medical Officer250,111Feb 26, 20240
Rice Steven J.Chief Administrative Officer106,840Jun 2, 20230
Sharp Phillip ADirector121,174May 24, 20230
Perez Robert JDirector15,806May 24, 20230
Friedl-Naderer JohannaEVP & Chief Operating Officer148,518Mar 7, 20230
Horn HowardCFO230,712Feb 24, 20230
Crandell Keith10% Owner61,160IndirectSep 7, 20220
Bybee Clinton10% Owner61,160IndirectSep 7, 20220
ARCH Venture Fund IX, L.P.10% Owner61,160IndirectSep 7, 20220
ARCH Venture Fund IX Overage, L.P.10% Owner61,160IndirectSep 7, 20220
ARCH Venture Partners IX Overage, L.P.10% Owner61,160IndirectSep 7, 20220
ARCH Venture Partners IX, L.P.10% Owner61,160IndirectSep 7, 20220
ARCH Venture Partners IX, LLC10% Owner61,160IndirectSep 7, 20220
Virgin HerbertEVP, Research & CSO262,500Aug 10, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 2, 2026 (view filing)Jun 11 dayNapolitano JanetDirectorSSale−3.20K$9.45−$30.2K−13.1%21.2K after10b5-1
Jun 2, 2026 (view filing)Jun 11 daySabatini BrentSVP, Chief Accounting OfficerSSale−379$9.45−$3.58K−0.6%61.9K after10b5-1
May 4, 2026 (view filing)May 13 daysSato Vicki LDirectorSSale−22.0K$10.05−$221.1K−2.0%1.08M after10b5-1
Apr 7, 2026 (view filing)Apr 61 dayDe Backer MariannePresident and CEOSSale−72.6K$9.16−$664.6K−7.1%948.1K after10b5-1
Apr 2, 2026 (view filing)Apr 11 daySato Vicki LDirectorSSale−22.0K$9.07−$199.5K−2.0%1.10M after10b5-1
Mar 24, 2026 (view filing)Mar 231 daySabatini BrentSVP, Chief Accounting OfficerSSale−7.71K$9.12−$70.3K−11.1%61.9K after10b5-1
Mar 3, 2026 (view filing)Mar 21 daySato Vicki LDirectorSSale−22.0K$9.50−$209.1K−1.9%1.12M after2 lots10b5-1
Feb 26, 2026 (view filing)Feb 242 daysSato Vicki LDirectorSSale−42.4K$9.75−$413.3K−3.6%1.14M after2 lots10b5-1
Feb 26, 2026 (view filing)Feb 242 daysSabatini BrentSVP, Chief Accounting OfficerSSale−1.43K$9.53−$13.6K−2.0%69.6K after10b5-1
Feb 26, 2026 (view filing)Feb 242 daysO'Byrne JasonEVP & Chief Financial OfficerSSale−1.63K$9.53−$15.6K−1.0%162.6K after10b5-1
Feb 26, 2026 (view filing)Feb 24-252 daysEisner MarkEVP and Chief Medical OfficerSSale−3.50K$9.69−$34.0K−2.2%154.0K after2 lots10b5-1
Feb 26, 2026 (view filing)Feb 24-252 daysde Verneuil VaninaEVP, General Counsel, Corp SecSSale−16.8K$9.77−$164.2K−13.0%113.0K after2 lots10b5-1
Feb 26, 2026 (view filing)Feb 242 daysDe Backer MarianneChief Executive OfficerSSale−14.8K$9.53−$140.7K−1.4%1.02M after10b5-1
Feb 24, 2026 (view filing)Feb 231 daySabatini BrentSVP, Chief Accounting OfficerSSale−1.83K$7.45−$13.6K−2.5%71.0K after10b5-1
Feb 24, 2026 (view filing)Feb 231 dayO'Byrne JasonEVP & Chief Financial OfficerSSale−2.09K$7.45−$15.6K−1.3%164.2K after10b5-1
Feb 24, 2026 (view filing)Feb 231 dayEisner MarkEVP and Chief Medical OfficerSSale−2.09K$7.45−$15.6K−1.3%157.5K after10b5-1
Feb 24, 2026 (view filing)Feb 231 dayde Verneuil VaninaEVP, General Counsel, Corp SecSSale−4.45K$7.45−$33.1K−3.3%129.8K after10b5-1
Feb 24, 2026 (view filing)Feb 231 dayDe Backer MarianneChief Executive OfficerSSale−19.0K$7.45−$141.8K−1.8%1.04M after10b5-1
Feb 18, 2026 (view filing)Feb 135 daysSabatini BrentSVP, Chief Accounting OfficerSSale−1.53K$7.79−$11.9K−3.1%47.9K after10b5-1
Feb 3, 2026 (view filing)Feb 21 daySato Vicki LDirectorSSale−22.0K$7.71−$169.6K−1.9%1.14M after10b5-1
Jan 5, 2026 (view filing)Jan 23 daysSato Vicki LDirectorSSale−22.0K$5.93−$130.5K−1.9%1.17M after10b5-1
Dec 3, 2025 (view filing)4:30 PM ETDec 12 daysSB Investment Advisers (UK) Ltd and 2 others10% OwnerSSale−191.9K$5.98−$1.15M−1.4%13.7M after10b5-1
Dec 2, 2025 (view filing)Dec 11 daySato Vicki LDirectorSSale−22.0K$6.00−$132.0K−1.8%1.19M after10b5-1
Dec 1, 2025 (view filing)4:30 PM ETNov 26-285 daysSB Investment Advisers (UK) Ltd and 2 others10% OwnerSSale−189.4K$6.41−$1.21M−1.3%13.9M after2 lots10b5-1
Nov 26, 2025 (view filing)4:30 PM ETNov 24-252 daysSB Investment Advisers (UK) Ltd and 2 others10% OwnerSSale−463.8K$6.27−$2.91M−3.2%14.1M after2 lots10b5-1
Nov 18, 2025 (view filing)Nov 171 dayO'Byrne JasonEVP & Chief Financial OfficerSSale−6.80K$5.56−$37.8K−5.8%110.7K after10b5-1
Nov 7, 2025 (view filing)Nov 52 daysde Verneuil VaninaEVP, General Counsel, Corp SecSSale−2.38K$5.16−$12.3K−3.0%78.2K after10b5-1
Nov 4, 2025 (view filing)Nov 31 dayde Verneuil VaninaEVP and General CounselSSale−1.36K$5.86−$8.00K−1.7%80.6K after10b5-1
Nov 4, 2025 (view filing)Nov 31 daySato Vicki LDirectorSSale−22.0K$5.64−$124.1K−1.8%1.21M after10b5-1
Oct 30, 2025 (view filing)4:30 PM ETOct 28-292 daysSB Investment Advisers (UK) Ltd and 2 others10% OwnerSSale−24.6K$6.50−$159.7K−0.2%14.6M after2 lots10b5-1
Oct 28, 2025 (view filing)4:30 PM ETOct 24-274 daysSB Investment Advisers (UK) Ltd and 2 others10% OwnerSSale−113.1K$6.01−$679.9K−0.8%14.6M after2 lots10b5-1
Oct 24, 2025 (view filing)4:30 PM ETOct 22-232 daysSB Investment Advisers (UK) Ltd and 2 others10% OwnerSSale−298.6K$6.07−$1.81M−2.0%14.7M after2 lots10b5-1
Oct 22, 2025 (view filing)4:30 PM ETOct 20-212 daysSB Investment Advisers (UK) Ltd and 2 others10% OwnerSSale−330.2K$6.23−$2.06M−2.2%15.0M after2 lots10b5-1
Oct 17, 2025 (view filing)4:15 PM ETOct 15-162 daysSB Investment Advisers (UK) Ltd and 2 others10% OwnerSSale−29.5K$6.08−$179.6K−0.2%15.3M after2 lots10b5-1
Oct 14, 2025 (view filing)4:30 PM ETOct 9-105 daysSB Investment Advisers (UK) Ltd and 2 others10% OwnerSSale−251.4K$6.14−$1.54M−1.6%15.4M after2 lots10b5-1
Oct 9, 2025 (view filing)4:30 PM ETOct 7-82 daysSB Investment Advisers (UK) Ltd and 2 others10% OwnerSSale−538.4K$5.99−$3.22M−3.3%15.6M after2 lots10b5-1
Oct 7, 2025 (view filing)4:30 PM ETOct 3-64 daysSB Investment Advisers (UK) Ltd and 2 others10% OwnerSSale−524.3K$5.57−$2.92M−3.1%16.2M after2 lots10b5-1
Oct 2, 2025 (view filing)Oct 11 daySato Vicki LDirectorSSale−22.0K$5.84−$128.5K−1.8%1.23M after10b5-1
Sep 3, 2025 (view filing)Sep 21 daySato Vicki LDirectorSSale−22.0K$4.99−$109.8K−1.7%1.25M after10b5-1
Aug 4, 2025 (view filing)Aug 13 daysSato Vicki LDirectorSSale−22.0K$4.99−$109.8K−1.7%1.28M after10b5-1
Jul 17, 2025 (view filing)Jul 15-172 daysEisner MarkEVP and Chief Medical OfficerSSale−10.4K$5.47−$56.8K−9.0%104.6K after2 lots10b5-1
Jul 2, 2025 (view filing)Jul 11 daySato Vicki LDirectorSSale−22.0K$5.10−$112.2K−1.7%1.30M after10b5-1
Jun 2, 2025 (view filing)Jun 2Same dayNapolitano JanetDirectorSSale−3.20K$5.05−$16.2K−16.3%16.4K after10b5-1
Apr 4, 2025 (view filing)Apr 31 dayDe Backer MarianneChief Executive OfficerSSale−79.7K$5.95−$474.3K−9.4%769.5K after10b5-1
Feb 27, 2025 (view filing)Feb 261 dayde Verneuil VaninaEVP and General CounselSSale−7.37K$9.14−$67.4K−8.5%79.5K after10b5-1
Feb 25, 2025 (view filing)Feb 241 dayScangos George ADirectorSSale−10.1K$9.45−$95.0K−1.4%698.2K after10b5-1
Feb 25, 2025 (view filing)Feb 241 dayHanly Ann M.EVP & Chief Technology OfficerSSale−14.2K$9.45−$133.9K−10.7%117.9K after10b5-1
Feb 25, 2025 (view filing)Feb 241 daySabatini BrentSVP, Chief Accounting OfficerSSale−1.56K$9.45−$14.8K−3.2%46.6K after10b5-1
Feb 25, 2025 (view filing)Feb 241 dayDe Backer MarianneChief Executive OfficerSSale−16.1K$9.45−$152.4K−1.9%849.2K after10b5-1
Feb 25, 2025 (view filing)Feb 241 dayde Verneuil VaninaEVP and General CounselSSale−5.14K$9.45−$48.6K−5.6%86.8K after10b5-1